Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease.[ Read More ]
The intrinsic value of one MDT stock under the base case scenario is HIDDEN Compared to the current market price of 87.5 USD, Medtronic plc is HIDDEN
Current Assets | 21.9 B |
Cash & Short-Term Investments | 8 B |
Receivables | 6.13 B |
Other Current Assets | 7.8 B |
Non-Current Assets | 68 B |
Long-Term Investments | 1.62 B |
PP&E | 7.14 B |
Other Non-Current Assets | 59.3 B |
Current Liabilities | 10.8 B |
Accounts Payable | 2.41 B |
Short-Term Debt | 1.28 B |
Other Current Liabilities | 7.1 B |
Non-Current Liabilities | 28.8 B |
Long-Term Debt | 24.8 B |
Other Non-Current Liabilities | 4 B |
Revenue | 32.4 B |
Cost Of Revenue | 12.9 B |
Gross Profit | 19.5 B |
Operating Expenses | 16.1 B |
Operating Income | 5.14 B |
Other Expenses | 1.47 B |
Net Income | 3.68 B |
Net Income | 3.68 B |
Depreciation & Amortization | 2.65 B |
Capital Expenditures | -1.59 B |
Stock-Based Compensation | 393 M |
Change in Working Capital | -484 M |
Others | 718 M |
Free Cash Flow | 5.2 B |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
5 months ago
Jun 07, 2024
|
Sell 1.47 M USD
|
Martha Geoffrey
Chairman and CEO |
- 17519
|
83.76 USD |
5 months ago
Jun 07, 2024
|
Sell 134 K USD
|
Martha Geoffrey
Chairman and CEO |
- 1594
|
83.82 USD |
7 months ago
Apr 08, 2024
|
Sell 71 K USD
|
Marinaro Michael
EVP & President, Surgical OU |
- 854
|
83.14 USD |
8 months ago
Feb 21, 2024
|
Sell 136 K USD
|
Salmon Sean
EVP & President Cardiovascular |
- 1594
|
85.06 USD |
8 months ago
Feb 21, 2024
|
Sell 1.11 M USD
|
Salmon Sean
EVP & President Cardiovascular |
- 13066
|
85.15 USD |
8 months ago
Feb 21, 2024
|
Sell 1.36 M USD
|
Salmon Sean
EVP & President Cardiovascular |
- 16035
|
85.12 USD |
10 months ago
Dec 19, 2023
|
Sell 411 K USD
|
Wall Brett A.
EVP & Pres Neuroscience |
- 4997
|
82.17 USD |
1 year ago
Aug 23, 2023
|
Sell 838 K USD
|
Smith Gregory L
EVP Global Ops & Supply Chain |
- 10000
|
83.84 USD |
1 year ago
Aug 14, 2023
|
Sell 83.4 K USD
|
Wall Brett A.
EVP & Pres Neuroscience |
- 1000
|
83.38 USD |
1 year ago
Aug 04, 2023
|
Sell 114 K USD
|
Marinaro Michael
EVP & President, Surgical OU |
- 1352
|
84.11 USD |
1 year ago
Jul 14, 2023
|
Sell 176 K USD
|
Wall Brett A.
EVP & Pres Neuroscience |
- 2000
|
87.97 USD |
1 year ago
Jul 10, 2023
|
Sell 157 K USD
|
TEN HOEDT ROB
EVP and Pres. Global Regions |
- 1808
|
86.59 USD |
1 year ago
Jul 10, 2023
|
Sell 321 K USD
|
TEN HOEDT ROB
EVP and Pres. Global Regions |
- 3706
|
86.58 USD |
1 year ago
Dec 13, 2022
|
Sell 1.34 M USD
|
Salmon Sean
EVP & President Cardiovascular |
- 16631
|
80.4964 USD |
2 years ago
Oct 14, 2022
|
Sell 196 K USD
|
TEN HOEDT ROB
EVP and Pres. Global Regions |
- 2404
|
81.537 USD |
2 years ago
Mar 18, 2022
|
Sell 75 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 682
|
110 USD |
2 years ago
Mar 11, 2022
|
Sell 632 K USD
|
Surface Carol A
SVP, Chief HR Officer |
- 6000
|
105.3 USD |
2 years ago
Dec 23, 2021
|
Sell 737 K USD
|
WHITE ROBERT JOHN
EVP & Pres. Medical Surgical |
- 7218
|
102.04 USD |
2 years ago
Dec 16, 2021
|
Bought 517 K USD
|
ANDERSON RICHARD H
Director |
+ 5010
|
103.26 USD |
2 years ago
Dec 06, 2021
|
Sell 75 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 682
|
110 USD |
3 years ago
Sep 30, 2021
|
Sell 6.22 M USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 49147
|
126.58 USD |
3 years ago
Aug 31, 2021
|
Sell 6.81 M USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 50775
|
134.17 USD |
3 years ago
Aug 25, 2021
|
Sell 978 K USD
|
Salmon Sean
EVP & Pres Diabetes/Cardiovasc |
- 7290
|
134.09 USD |
3 years ago
Aug 25, 2021
|
Sell 2.83 M USD
|
Salmon Sean
EVP & Pres Diabetes/Cardiovasc |
- 21129
|
134.08 USD |
3 years ago
Aug 25, 2021
|
Sell 1.34 M USD
|
Martha Geoffrey
CEO |
- 10100
|
132.67 USD |
3 years ago
Aug 02, 2021
|
Sell 526 K USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 4000
|
131.52 USD |
3 years ago
Jun 28, 2021
|
Sell 1.44 M USD
|
Martha Geoffrey
CEO |
- 11500
|
125.29 USD |
3 years ago
Jun 21, 2021
|
Sell 14.2 K USD
|
Wall Brett A.
EVP & Pres Neuroscience |
- 115
|
123.5 USD |
3 years ago
Jun 15, 2021
|
Sell 75.3 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 605
|
124.47 USD |
3 years ago
Jun 01, 2021
|
Sell 317 K USD
|
Wall Brett A.
EVP & Pres Neuroscience |
- 2473
|
128.07 USD |
3 years ago
May 28, 2021
|
Sell 4.39 M USD
|
Liddicoat John R
EVP & President of Americas |
- 34656
|
126.65 USD |
3 years ago
Apr 05, 2021
|
Sell 1.11 M USD
|
Martha Geoffrey
CEO |
- 9308
|
118.83 USD |
3 years ago
Mar 15, 2021
|
Sell 75.3 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 632
|
119.12 USD |
3 years ago
Mar 02, 2021
|
Sell 846 K USD
|
TEN HOEDT ROB
EVP & President EMEA |
- 7168
|
117.98 USD |
3 years ago
Dec 28, 2020
|
Sell 1.72 M USD
|
Surface Carol A
SVP, Chief HR Officer |
- 15000
|
114.9 USD |
3 years ago
Dec 22, 2020
|
Sell 301 K USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 2605
|
115.56 USD |
3 years ago
Dec 18, 2020
|
Sell 1.26 M USD
|
WHITE ROBERT JOHN
EVP & Pres. Medical Surgical |
- 10930
|
115.46 USD |
3 years ago
Dec 15, 2020
|
Sell 76.6 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 670
|
114.33 USD |
4 years ago
Nov 09, 2020
|
Sell 2.34 M USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 20715
|
113.13 USD |
4 years ago
Oct 09, 2020
|
Sell 82.7 K USD
|
ISHRAK OMAR
Executive Chairman |
- 763
|
108.4 USD |
4 years ago
Oct 08, 2020
|
Sell 87.7 K USD
|
Lerman Bradley E
SVP General Counsel & Corp Sec |
- 797
|
110 USD |
4 years ago
Oct 08, 2020
|
Bought 500 K USD
|
ANDERSON RICHARD H
Director |
+ 4607
|
108.52 USD |
4 years ago
Sep 23, 2020
|
Sell 1 M USD
|
TEN HOEDT ROB
EVP & President EMEA |
- 9584
|
104.34 USD |
4 years ago
Sep 15, 2020
|
Sell 75.7 K USD
|
PARKHILL KAREN L
EVP & Chief Financial Officer |
- 702
|
107.78 USD |
4 years ago
Sep 09, 2020
|
Sell 1 M USD
|
TEN HOEDT ROB
EVP & President EMEA |
- 9563
|
105.05 USD |
4 years ago
May 29, 2020
|
Sell 195 K USD
|
Surface Carol A
SVP, Chief HR Officer |
- 2000
|
97.72 USD |
4 years ago
Feb 20, 2020
|
Bought 997 K USD
|
ISHRAK OMAR
Chairman & CEO |
+ 8771
|
113.68 USD |